A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic ...

Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2 ...

In this article, we will review the pharmacology and mechanisms of action of LCM, and evaluate its efficacy and safety as adjunctive therapy at daily doses of up to 400 mg in patients with ...

Outstanding questions on the prothrombotic potential of lipoprotein (a) remain to be answered, particularly the mechanisms by which lipoprotein (a) can impact thrombosis beyond a role in fibrinolysis ...

In this GEN webinar, Dave Lahr, PhD, Senior Director of Bioinformatics at Foghorn Therapeutics, discusses chromatin regulation and epigenetic mechanisms that shape transcriptional responses to ...